3:30 PM Panel Discussion: Lessons Learnt from Successful Clinical Trials in IgAN & C3G to Inform Successful Clinical Design & Development in Wider Rare & Genetic Kidney Diseases
Time: 3:30 pm
day: Conference Day 1
Details:
- Advancing understanding of disease pathophysiology and biomarker identification to guide the development of therapies with distinguished mechanism of actions
- Discussing suitable design of placebo arm and standard of care for rare diseases
- Examining the importance of integrating patient-reported outcomes, quality of like measures and comparative effectiveness research early in clinical development to demonstrate meaningful differentiation
